These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

498 related articles for article (PubMed ID: 33185241)

  • 21. Exclusion of bacterial co-infection in COVID-19 using baseline inflammatory markers and their response to antibiotics.
    Mason CY; Kanitkar T; Richardson CJ; Lanzman M; Stone Z; Mahungu T; Mack D; Wey EQ; Lamb L; Balakrishnan I; Pollara G
    J Antimicrob Chemother; 2021 Apr; 76(5):1323-1331. PubMed ID: 33463683
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibiotic Use and Bacterial Infection among Inpatients in the First Wave of COVID-19: a Retrospective Cohort Study of 64,691 Patients.
    Baghdadi JD; Coffey KC; Adediran T; Goodman KE; Pineles L; Magder LS; O'Hara LM; Pineles BL; Nadimpalli G; Morgan DJ; Harris AD
    Antimicrob Agents Chemother; 2021 Oct; 65(11):e0134121. PubMed ID: 34491806
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coronavirus disease 2019 (COVID-19) associated bacterial coinfection: Incidence, diagnosis and treatment.
    Wu HY; Chang PH; Chen KY; Lin IF; Hsih WH; Tsai WL; Chen JA; Lee SS;
    J Microbiol Immunol Infect; 2022 Dec; 55(6 Pt 1):985-992. PubMed ID: 36243668
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pulmonary bacterial infections in adult patients hospitalized for COVID-19 in standard wards.
    Husain M; Valayer S; Poey N; Rondinaud E; d'Humières C; Visseaux B; Lariven S; Lescure FX; Deconinck L
    Infect Dis Now; 2022 Jun; 52(4):208-213. PubMed ID: 34896662
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Procalcitonin-Guided Antibiotic Prescription in Patients With COVID-19: A Multicenter Observational Cohort Study.
    Hessels LM; Speksnijder E; Paternotte N; van Huisstede A; Thijs W; Scheer M; van der Steen-Dieperink M; Knarren L; van Den Bergh JP; Winckers K; Henry R; Simsek S; Boersma WG;
    Chest; 2023 Sep; 164(3):596-605. PubMed ID: 37116748
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bacterial infection, antibiotic use and COVID-19: Lessons from the intensive care unit.
    Moolla MS; Reddy K; Fwemba I; Nyasulu PS; Taljaard JJ; Parker A; Louw EH; Nortje A; Parker MA; Lalla U; Koegelenberg CFN; Allwood BW
    S Afr Med J; 2021 Apr; 111(6):575-581. PubMed ID: 34382570
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bacterial and Fungal Coinfection in Individuals With Coronavirus: A Rapid Review To Support COVID-19 Antimicrobial Prescribing.
    Rawson TM; Moore LSP; Zhu N; Ranganathan N; Skolimowska K; Gilchrist M; Satta G; Cooke G; Holmes A
    Clin Infect Dis; 2020 Dec; 71(9):2459-2468. PubMed ID: 32358954
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Co-infection and ICU-acquired infection in COIVD-19 ICU patients: a secondary analysis of the UNITE-COVID data set.
    Conway Morris A; Kohler K; De Corte T; Ercole A; De Grooth HJ; Elbers PWG; Povoa P; Morais R; Koulenti D; Jog S; Nielsen N; Jubb A; Cecconi M; De Waele J;
    Crit Care; 2022 Aug; 26(1):236. PubMed ID: 35922860
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characteristics of COVID-19 patients with bacterial coinfection admitted to the hospital from the emergency department in a large regional healthcare system.
    Lardaro T; Wang AZ; Bucca A; Croft A; Glober N; Holt DB; Musey PI; Peterson KD; Trigonis RA; Schaffer JT; Hunter BR
    J Med Virol; 2021 May; 93(5):2883-2889. PubMed ID: 33448423
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antimicrobial prescription in severe COVID-19 and CAP: a matched case-control study.
    Fierens J; De Bus L; Colpaert K; Boelens J; Gadeyne B; Decruyenaere J; Van Braeckel E; Depuydt P
    Acta Clin Belg; 2022 Oct; 77(5):837-844. PubMed ID: 34709997
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antimicrobial use in patients with confirmed COVID-19 infection in the Philippines: a cross-sectional study.
    Dominguez RJ; Domingo-Cereno NA; Josue-Dominguez RT
    Western Pac Surveill Response J; 2023; 14(2):1-8. PubMed ID: 37475781
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidemiology of bacterial co-infections and risk factors in COVID-19-hospitalized patients in Spain: a nationwide study.
    López-Herrero R; Sánchez-de Prada L; Tamayo-Velasco A; Lorenzo-López M; Gómez-Pesquera E; Sánchez-Quirós B; de la Varga-Martínez O; Gómez-Sánchez E; Resino S; Tamayo E; Álvaro-Meca A
    Eur J Public Health; 2023 Aug; 33(4):675-681. PubMed ID: 37087109
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Difference in the impact of coinfections and secondary infections on antibiotic use in patients hospitalized with COVID-19 between the Omicron-dominant period and the pre-Omicron period.
    Murakami Y; Nozaki Y; Morosawa M; Toyama M; Ogashiwa H; Ueda T; Nakajima K; Tanaka R; Takesue Y
    J Infect Chemother; 2024 Sep; 30(9):853-859. PubMed ID: 38428674
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elucidating the role of procalcitonin as a biomarker in hospitalized COVID-19 patients.
    Cowman K; Rossi J; Gendlina I; Guo Y; Liu S; Szymczak W; Forest SK; Wolgast L; Orner E; Bao H; Cervera-Hernandez ME; Ceniceros A; Thota R; Pirofski LA; Nori P
    Diagn Microbiol Infect Dis; 2022 Aug; 103(4):115721. PubMed ID: 35635888
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic yield of bacteriological tests and predictors of severe outcome in adult patients with COVID-19 presenting to the emergency department.
    Kaal A; Snel L; Dane M; van Burgel N; Ottens T; Broekman W; El Bouazzaoui L; Kolfschoten N; Schippers E; Steyerberg E; Meziyerh S; van Nieuwkoop C
    Emerg Med J; 2021 Sep; 38(9):685-691. PubMed ID: 34289966
    [TBL] [Abstract][Full Text] [Related]  

  • 36. State-of-the-art review of secondary pulmonary infections in patients with COVID-19 pneumonia.
    Chong WH; Saha BK; Ananthakrishnan Ramani ; Chopra A
    Infection; 2021 Aug; 49(4):591-605. PubMed ID: 33709380
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Comparative Study on Bacterial Co-Infections and Prevalence of Multidrug Resistant Organisms among Patients in COVID and Non-COVID Intensive Care Units.
    Sathyakamala R; Peace AR; Shanmugam P
    J Prev Med Hyg; 2022 Mar; 63(1):E19-E26. PubMed ID: 35647371
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cross-sectional observational study of epidemiology of COVID-19 and clinical outcomes of hospitalised patients in North West London during March and April 2020.
    Gopal Rao G; Allen A; Papineni P; Wang L; Anderson C; McGregor A; Whittington A; John L; Harris M; Hiles S; Nicholas T; Adams K; Akbar A; Blomquist P; Decraene V; Patel B; Manuel R; Chow Y; Kuper M;
    BMJ Open; 2021 Feb; 11(2):e044384. PubMed ID: 33602712
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk factors and outcomes associated with community-onset and hospital-acquired coinfection in patients hospitalized for coronavirus disease 2019 (COVID-19): A multihospital cohort study.
    Petty LA; Flanders SA; Vaughn VM; Ratz D; O'Malley M; Malani AN; Washer L; Kim T; Kocher KE; Kaatz S; Czilok T; McLaughlin E; Prescott HC; Chopra V; Gandhi T
    Infect Control Hosp Epidemiol; 2022 Sep; 43(9):1184-1193. PubMed ID: 34308805
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SARS-CoV-2 and Chlamydia pneumoniae co-infection: A review of the literature.
    Frutos MC; Origlia J; Gallo Vaulet ML; Venuta ME; García MG; Armitano R; Cipolla L; Madariaga MJ; Cuffini C; Cadario ME;
    Rev Argent Microbiol; 2022; 54(3):247-257. PubMed ID: 35931565
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.